Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Stem Cells Market to Cross US$ 297 Billion by 2022

Market Research Engine
Posted on: 29 Sep 16
Stem Cells Market to Cross US$ 297 Billion by 2022

Florida, September 29: Market Research Engine adds a new research study on the report, titled “Global Stem Cells Market Analysis by Therapy, Application and Geography - Trends and Forecast, 2015 - 2022”.

The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2015 to 2022 and reach a market value of US$297 billion by 2022.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/global-stem-cells-market-analysis-report

The emergence of Induced Pluripotent Stem (iPS) cells as an alternative to ESCs (embryonic stem cells), growth of developing markets, and evolution of new stem cell therapies represent promising growth opportunities for leading players in this sector.

Due to the increased funding from Government and Private sector and rising global awareness about stem cell therapies and research are the main factors which are driving this market. A surge in therapeutic research activities funded by governments across the world has immensely propelled the global stem cells market. However, the high cost of stem cell treatment and stringent government regulations against the harvesting of stem cells are expected to restrain the growth of the global stem cells market.

This report will definitely help you make well informed decisions related to the stem cell market.

The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe.

Browse Full Report from here: https://www.marketresearchengine.com/reportdetails/global-stem-cells-market-analysis-report
Scope of the Report

This market research report categorizes the stem cell therapy market into the following segments and sub-segments:

By Mode of Therapy

•    Allogeneic Stem Cell Therapy Market  
o    CVS Diseases
o    CNS Diseases
o    GIT diseases
o    Eye Diseases
o    Musculoskeletal Disorders
o    Metabolic Diseases
o    Immune System Diseases
o    Wounds and Injuries
o    Others
•    Autologous Stem Cell Therapy Market  
o    GIT Diseases
o    Musculoskeletal Disorders
o    CVS Diseases
o    CNS Diseases
o    Wounds and Injuries
o    Others

By Therapeutic Applications

•    Musculoskeletal Disorders
•    Metabolic Diseases
•    Immune System Diseases
•    GIT Diseases
•    Eye Diseases
•    CVS Diseases
•    CNS Diseases
•    Wounds and Injuries
•    Others

By Geography

•    North America
•    Europe
•    Asia-Pacific  
•    RoW (Rest of the World)

For more information:
www.marketresearchengine.com

Editor's Details

John Bay
Market Research Engine
www.marketresearchengine.com
1-855-984-1862
john@marketresearchengine.com

Last updated on: 29/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.